AMPH · Amphastar Pharmaceuticals Inc
United States · RS rating 82 · As of 2026-11-03
| Price | 27.12 USD |
|---|---|
| 1-day change | +0.3% |
| RS rating (overall / 1M / 3M / 12M) | 82 / 76 / 93 / 57 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 39 / 45 / 42 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +37.8% |
| Sales growth Q/Q | -4.5% |
| Distance from 52-week high | +7.8% |
| Market cap (USD) | $935.7M |